The 3rd International Electronic Conference on Nutrients
Precision Nutrition and Nutrigenomics
Part of the International Electronic Conference on Nutrients series
1–15 Nov 2023
Precision Nutrition, Nutrigenomics, Genetics
- Go to the Sessions
- Event Details
The IECN 2023 is closed!
Thank you for your participation.
The winners of the IECN 2023 awards will be announced shortly.
The accepted proceedings papers will be published as one dedicated volume in MDPI Biology and Life Sciences Forum (ISSN 2673-9976). Publication of proceedings paper is free of charge.
Participants of this conference are cordially invited to contribute a full manuscript to a dedicated Special Issue in the journal Nutrients (ISSN 2072-6643, IF 5.9). Papers presented at the conference will be granted a 20% discount in the Special Issue.
Live Session Registration
Can’t attend? Register anyway and we’ll let you know when the recording is available to watch.
Any question? Feel free to contact us at: iecn2023@mdpi.com
Four live sessions will be held on 2, 6, 9, 14 November 2023.
IECN 2023 | Live Session I
Date: 2 November 2023
Time: 15:00 (CET) | 10:00 (EDT) | 22:00 (CST Asia) |
|
IECN 2023 | Live Session II
Date: 6 November 2023
Time: 15:00 (CET) | 09:00 (EST) | 22:00 (CST Asia) |
|
IECN 2023 | Live Session III
Date: 9 November 2023
Time: 16:00 (CET) | 10:00 (EST) | 23:00 (CST Asia) |
|
IECN 2023 | Live Session IV
Date: 14 November 2023
Time: 16:00 (CET) | 10:00 (EST) | 23:00 (CST Asia) |
Live Session Program
IECN 2023 | Live Session IDate: 2 November 2023
|
Time in CET |
Speaker |
Title |
15:00-15:10 |
Dr. Francisco J Pérez-Cano |
Opening Speech |
15:10-15:40 |
Dr. Francisco Guarner |
Digestive and Metabolic Functions of Gut Microbes |
15:40-16:10 |
Dr. Alex Mira |
The Oral Microbiome: Diet-mediated local and systemic effects |
16:10-16:40 |
Dr. Omry Koren
Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel |
The microbiome in the first 1000 days of life |
16:40-17:00 |
Discussion and Q&A |
Time in CET |
Speaker |
Title |
15:00-15:10 |
Prof. Dr. M Luisa Bonet |
Opening Speech |
15:10-15:30 |
Dr. Fermin I. Milagro |
Epigenetic information in the implementation of precision nutrition in obesity |
15:30-15:50 |
Dr. Juana Sánchez |
microRNAs in breastmilk and their potential epigenetic effects |
15:50-16:10 |
Dr. Albert Salas-Huetos
Preventive Medicine and Public Health, Rovira i Virgili University, Reus, Spain |
Epigenetically mediated effects of paternal diet on sperm quality and offspring health |
16:10-16:30 |
Prof. Dr. Agata Chmurzyńska |
Epigenetic control and obesity |
16:30-16:50 |
Discussion and Q&A |
IECN 2023 | Live Session III
Date: 9 November 2023
|
Time in CET
|
Speaker
|
Title
|
16:00-16:10
|
Dr. Egeria Scoditti
National Research Council –Institute of Clinical Physiology, Lecce Section, Laboratory of Vascular Biology and Nutrigenomics, Ecotekne Campus, Via Monteroni, 73100 Lecce, Italy |
Opening Speech |
16:10-16:40
|
Prof. Dr. Tatjana Ruskovska
Faculty of Medical Sciences, Goce Delcev University, Krste Misirkov 10A, 2000, Stip, North Macedonia |
Multi-omics and integrative bioinformatic analyses towards precision nutrition for (poly)phenols and cardiometabolic health |
16:40-17:10
|
Dr. Dragan Milenkovic
Department of Nutrition, College of Agricultural and Environmental Sciences, University of California, Davis, CA 95616, USA
|
Multiomics in nutrition and vascular health: from genomics to precise nutrition |
17:10-17:40
|
Dr. Pedro Mena
University of Parma, Italy |
Phenolic compounds for precision nutrition |
17:40-18:00
|
Discussion and Q&A
|
IECN 2023 | Live Session IV
Date: 14 November 2023
|
Time in CET
|
Speaker
|
Title
|
16:00-16:10
|
Prof. Dr. Maria Luz Fernandez |
Opening Speech |
16:10-16:40
|
Dr. Catherine Andersen |
Modulation of immune cell function and gene expression profiles by egg intake: Implications for personalized nutrition |
16:40-17:10
|
Dr. Jim Kaput |
The Effect of Polygenic Risk Scores on Interindividual Variability of Vitamin B12 Levels |
17:10-17:40
|
Prof. Floyd Chilton |
Why Precision Nutrition? The Impact of Gene by Diet Interactions on Inflammation, Cardiometabolic Disease, Health Disparities, and the Effectiveness of Omega-3 Supplementation |
17:40-18:00
|
Discussion and Q&A
|
Live Session Recordings
Live Session 1 (2 November 2023)
Live Session 2 (6 November 2023)
Live Session 3 (9 November 2023)
Live Session 4 (14 November 2023)
Welcome from the Chairs
Dear researchers,
We are pleased to announce the Third Electronic Conference sponsored by Nutrients. The focus of this conference will be on Precision Nutrition and Nutrigenomics. Precision Nutrition, a novel individualized approach, considers the genetic and epigenetic information as well as age, gender, lifestyle, gut microbiota, and health status conditions to design the best dietary approaches for an individual in order to achieve optimal health and ageing, disease prevention and improved exercise performance. This conference will provide updated information and novel findings on the role of epigenetics, genetic polymorphisms and the microbiota in Precision Nutrition as well as the use of “omics” as necessary tools to discover unsuspected interactions and interpret the information.
Participants will have the opportunity to examine, explore and actively participate in current issues and advances in these areas. We hope to facilitate discussions and exchanges within the community. This event will solely be an online proceeding that allows participation from all over the world with no concerns about travel and related expenditures. This type of conference is particularly appropriate and useful because of the discussion on new findings on Precision Nutrition and Nutrigenomics . An electronic conference provides a platform for rapid and direct exchanges about the latest research findings and novel ideas. The participation in, as well as the “attendance” of, this online conference is free of charge.
Prof. Dr. Maria Luz Fernandez
Prof. Dr. M. Luisa Bonet
Dr. Francisco J. Pérez-Cano
The Chairs of the IECN 2023
Important: Please kindly note that there are no registration fees for this conference as it is free of charge.
Event Chairs
Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA
Interests: lipoprotein metabolism; functional foods; eggs; metabolic syndrome; diabetes
maria-luz.fernandez@uconn.edu
Laboratory of Molecular Biology, Nutrition, and Biotechnology. University of the Balearic Islands, 07122 Palma, Spain
Interests: Obesity; molecular nutrition; nutrigenomics; vitamin A; food bioactives
luisabonet@uib.es
Section of Physiology, Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain, Nutrition and Food Safety Research Institute (INSA), 08921 Santa Coloma de Gramenet, Spain
Interests: immunonutrition; flavonoids; microbiota; oligosaccharides; probiotics; breast milk
franciscoperez@ub.edu
Event Committee
Department of Food Science, Nutrition and Physiology, University of Navarra, 31008 Pamplona, Spain
children obesity; Mediterranean diet; adiposity; nutrition; lifestyle intervention studies; genetic and epigenetic markers of obesity; telomere length
amarti@unav.es
Department of Biology, Appalachian State University, Boone, NC 28608, USA, Director of the Human Performance Laboratory, North Carolina Research Campus, Kannapolis, NC 28081, USA
sports nutrition; exercise; immunology; inflammation; obesity; metabolomics; proteomics; lipid mediators
niemandc@appstate.edu
National Research Council –Institute of Clinical Physiology, Lecce Section, Laboratory of Vascular Biology and Nutrigenomics, Ecotekne Campus, Via Monteroni, 73100 Lecce, Italy
nutrition; signaling pathways; chronic disease; genomics; cardiometabolic diseases; inflammation; oxidative stress; miRNAs
egeria.scoditti@ifc.cnr.it
Department of Clinical Sciences, Faculty of Medicine, Polytechnic University of Marche, 60131 Ancona, Italy,
Research Group on Foods, Nutritional Biochemistry and Health, Universidad Europea del Atlántico, Isabel Torres 21, 39011 Santander, Spain
nutrition; health; disease prevention; dietary bioactive compounds; oxidative stress; aging; mitochondrial functionality; inflammation; bioenergetics
f.giampieri@univpm.at
Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
diabetes; chronic kidney disease; dietary advanced glycation end products; dietary phosphorus; acid-base metabolism
jaime.uribarri@mssm.edu
Department of Food Sciences and Human Nutrition, University of Illinois, Urbana-Champaign, Urbana, IL 61801, USA
carotenoids; retinoids; atherosclerosis; obesity; lipoproteins; nutrigenomics
jaume6@illinois.edu
Department of Biomedical and Biotechnological Sciences, University of Catania, 95123 Catania, Italy
coffee; polyphenol-rich foods; polyphenols; Mediterranean diet; neurodegenerative diseases; sleep; mental health
justyna.godos@gmail.com
Growth, Exercise, Nutrition and Development (GENUD) Research Group, Instituto Agroalimentario de Aragón (IA2), Instituto de Investigación Sanitaria de Aragón (IIS Aragón), Universidad de Zaragoza, 50009 Zaragoza, Spain
pediatric nutrition; childhood obesity; body composition; nutritional status; nutritional epidemiology; lifestyle behaviors
lmoreno@unizar.es
Food Bioscience Group, Department of Bioactivity and Food Analysis, Institute of Food Science Research (CIAL), Spanish National Research Council (CSIC) and the Autonoma University of Madrid (UAM), Nicolás Cabrera 9, 28049 Madrid, Spain
bioactive compounds; diet; dietary fiber; food processing and health; food quality and safety; functional foods; human nutrition and health; novel ingredients and foods; food waste recovery into healthy ingredients
mdolores.delcastillo@csic.es
Department of Allied Health Science, College of Agriculture, Health, and Natural Resources, University of Connecticut, 358 Mansfield Road, Box U-101 Storrs, CT 06269-2101, USA
taste; smell, food preference; sweet; bitter; diet quality; ingestive behaviors; community nutrition; sensory analysis
valerie.duffy@uconn.edu
Department of Human Health and Nutritional Sciences, University of Guelph, Guelph, ON, Canada
nutritional genomics; gene expression; cardiovascular disease and insulin resistance
mbakovic@uoguelph.ca
National Research Council (CNR) Institute of Clinical Physiology (IFC), 73100 Lecce, Italy
pathogenesis of chronic disese; nutri- and pharmacogenomics applied to obesity and cardiovascular disease prevention; analysis of the anti-aterogenic and anti-inflammatory properties of nutritional fatty acids and plant food bioactives in the field of vas
marika@ifc.cnr.it
School of Chemistry and Molecular Biosciences, The University of Queensland, St Lucia, QLD 4072, Australia
microbiome; pregnancy; obesity; hypertension; diabetes
m.dekker@uq.edu.au
Department of Biomedical Sciences, Division of Neuroscience and Clinical Pharmacology, University of Cagliari, 09042 Monserrato, Italy
psychiatric disorders; eating disorders; addiction; dopaminergic system; endocannabinoid system; behavioral neuroscience; eating behavior; animal models of eating disorders
pfadda@unica.it
Dipartimento di Scienze e Tecnologie Ambientali, Biologiche e Farmaceutiche, Università Degli Studi Della Campania “Luigi Vanvitelli”, Via Vivaldi 43, 81130 Caserta, Italy
thyronine; obesity; molecular biology; lipid metabolism; metabolic diseases
pieter.delange@unicampania.it
Department of Epidemiology and Population Health, Albert Einstein College of Medicine, Bronx, NY 10461, USA
epidemiological studies of obesity and related cariometabolic disease (diabetes and CVD); genetic and gene-environment interaction studies; metabolomics; gut Microbiome; cariometabolic disease in HIV infection
qibin.qi@einsteinmed.org
Department of Medicine, Division of Endocrinology, Diabetes, and Metabolism, College of Medicine, University of Illinois at Chicago, Chicago, IL 60612, USA
cardiovascular disease; obesity; diabetes; metabolic disease; vascular biology; exercise physiology; molecular biology; pathology; nutrition; epigenetics; translational research; dietary interventions; biomarkers; chemoprevention; cancer biology; racial d
amahmo4@uic.edu
Department of Health Science and Biostatistics, Faculty of Health, Arts and Design, Swinburne University of Technology, Hawthorn, VIC, 3122, Australia
metabolism; diet; microbiome; nutrigenomics; muscle; performance; health
matt.cooke@vu.edu.au
Laboratory of Molecular Biology, Nutrition and Biotechnology. University of Balearic Islands (UIB), Carretera de Valldemossa, km 7.5. 07122 Palma. Spain
Obesity; Gene-nutrients interaction; Impact of perinatal diet (Epigenetics) on adulthood obesity; Functional foods; Personalized nutrition; Diet profiling; Nutrition app; Development of tools to empower consumers towards healthier diets and lifestyle
francisca.serra@uib.es
Metabolic Research Lab, Clínica Universidad de Navarra, Irunlarrea 1, 31008 Pamplona, Spain
obesity; dietary treatment; lifestyle intervention; pharmacological treatment; metabolic surgery; intermittent fasting; cardiometabolic risk improvement; body composition changes
jagomez@unav.es
Department of Nutrition, University of Nevada, Reno, NV 89557, USA
lysine acetylation; muscle function; cardiac function; heart failure; nutritional epigenetics; food bioactives
bferguson@unr.edu
Pollenzo Campus, University of Gastronomic Sciences, Piazza Vittorio Emanuele 9, Bra, 12042 Pollenzo, CN, Italy
chemosensory perception; sensory nutrition; taste genetics; taste receptors and health; onthogenesis and education of taste
g.morini@unisg.it
Inserm U1065 C3M, Team Control of Gene Expression (10), Université Côte d’Azur, 151 Route de Ginestière, 06204 Nice CEDEX 3, France
epigenetics; mouse models; epigenetic inheritance related to Cardio-metabolic diseases; small non coding RNA; germinal lineage
valerie.grandjean@unice.fr
Cardiovascular ICCC-Program, Research Institute Hospital de la Santa Creu i Sant Pau, IIB-Sant Pau, 08025 Barcelona, Spain
nutrition; inflammation; thrombosis; atherosclerosis; systems biology and epigenetics
lbadimon@santpau.cat
Department of Biochemistry and Pharmacogenomics, Faculty of Pharmacy, Medical University of Warsaw, Banacha 1B, 02-097 Warsaw, Poland
biochemistry and molecular medicine; molecular and cellular mechanisms of disease pathogenesis; biomarkers in disease diagnosis; assessment of therapy effectiveness; pharmacogenomics and nutrigenomics; diet related disorders; atherosclerosis; obesity; obe
grazyna.nowicka@wum.edu.pl
immune system; macrophages; microglia; inflammation; cytokines; Alzheimer\'s disease; atherosclerosis; diet as non pharmacological treatment for chronic degenerative diseases; ketogenic diet; diet for treatment of hyperbaric risk
rita.businaro@uniroma1.it
Laboratory of Molecular Biology, Nutrition and Biotechnology, University of the Balearic Islands (UIB), Palma, Illes Balears, Spain,
Instituto de Investigación Sanitaria Illes Balears (IdISBa), Palma, Illes Balears, Spain,
CIBER de Fisiopatología de la Obesidad y Nutrición (CIBERobn), ES-07122 Palma de Mallorca, Spain
perinatal programming; obesity; nutrigenomics; breast milk; leptin
mariona.palou@uib.cat
School of Basic Pharmaceutical and Toxicological Sciences, College of Pharmacy, University of Louisiana at Monroe, 1800 Bienville Drive, Monroe, LA 71201, USA
skin health and diseases; carcinogenesis; inflammation; dermatology; psoriasis; atopic dermatitis; bioactive natural products; antioxidants; polyphenols; flavonoids; tissue engineering; signaling pathways; pharmacology
chamcheu@ulm.edu
Metabolic Bone Diseases Research Group, University of Extremadura, 10003 Cáceres, Spain
https://www.unex.es/conoce-la-uex/centros/enfermeria/centro/profesores/info/profesor?id_pro=jmmorang
genetics of bone density; nutrition and women bone health; polyunsaturated fatty acid intake and women bone health
jmmorang@unex.es
School of Exercise and Sport Science, Mayborn College of Health Sciences, University of Mary Hardin-Baylor, 900 College St, Belton, TX 76513, USA
Exercise/Muscle Physiology and Biochemistry; Exercise/Sport Nutrition; Nutritional Biochemistry and Metabolism; Molecular Physiology and Nutrigenetics
dwilloughby@umhb.edu
Departments of Clinical Nutrition & Preventive Medicine, Associate Dean for Research, College of Health Sciences, Rush University Medical Center, 600 S Paulina St, Room 716 ACC, Chicago, IL 60612, USA
dietary patterns; Mediterranean; DASH; MIND; dietary assessment; neurodegenerative disease; parkinson’s and Alzheimers diseases; cognitive decline; vitamin E; women’s cardiovascular and cognitive health
ctangney@rush.edu
Division of Renal Diseases & Hypertension, Department of Medicine, The George Washington University School of Medicine and Health Sciences, Washington, DC 20052, USA
hypertension; blood pressure regulation; renal physiology; pharmacogenomics; reactive oxygen species; sodium balance
pjose@mfa.gwu.edu
Department of Molecular Biosciences, School of Veterinary Medicine, University of California, Davis, CA 95616, USA
sugar; diet; non-nutritive sweeteners; sucrose; high-fructose corn syrup; aspartame; fructose; sucralose; saccharine; energy intake; energy balance; de novo lipogenesis; cardiovascular disease; type 2 diabetes; metabolic syndrome
klstanhope@ucdavis.edu
Department DI.PE.CA, Geriatric Unit, University Hospital AOUP, University of Palermo, 90127 Palermo, Italy
Mediterranean diet; aging; diabetes; hypertension; dementia; magnesium
mario.barbagallo@unipa.it
Human Nutrition and Mebolomics, Pomeranian Medical University, ul Broniewskiegi 24, Szczecin, Poland
nutrition in liver diseases; non-alcoholic fatty liver disease; nutrigenetics; gut microbiota and its impact on liver function
ewa.stachowska@pum.edu.pl
Clinica Medica Cesare Frugoni, Department of Interdisciplinary Medicine, University of Bari “Aldo Moro”, 70124 Bari, Italy
nutrients; nuclear receptors; gut-liver axis; tumorigenesis; cholesterol and lipid metabolism
maricacariello@gmail.com
Session Chairs
Prof. Dr. M. Luisa Bonet
SEIC of Nutrients Nutrigenomic and Obesity Research Group, Laboratory of Molecular Biology, Nutrition and Biotechnology (LBNB), University of the Balearic Islands, Palma de Mallorca, Spain
Prof. Dr. Maria Luz Fernandez
Department of Nutritional Sciences, University of Connecticut, Storrs, CT 06269, USA
Dr. Francisco J. Pérez-Cano
Section of Physiology, Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain, Nutrition and Food Safety Research Institute (INSA), 08921 Santa Coloma de Gramenet, Spain
Dr. Egeria Scoditti
National Research Council –Institute of Clinical Physiology, Lecce Section, Laboratory of Vascular Biology and Nutrigenomics, Ecotekne Campus, Via Monteroni, 73100 Lecce, Italy
Invited Speakers
Genomics and Health Department, Foundation for the Promotion of Health and Biomedical Research (FISABIO), 46020 Valencia, Spain
Alex Mira is the head of the Oral Microbiome Lab at the FISABIO Institute in Valencia, Spain. After a PhD at Oxford University and postdoctoral stays in the USA and Sweden, returned to Spain to focus on the study of the human microbiome, especially in the oral cavity. His team performed the first metagenome and metatranscriptome of the human dental plaque, through which he discovered the new species Streptococcus dentisani, currently being developed as an oral probiotic. After working on the microbial etiology of oral diseases, he is currently focused on studying the systemic effect of the oral microbiome, ranging from colorectal cancer to cardiovascular or antidiabetic effects.
Digestive System Research Unit, University Hospital Vall d’Hebron, 08035 Barcelona, Spain
Diet is central to the mutualistic relationship between microbiome and host. The host provides habitat and food, and the microbiome participates in the digestion and metabolism of food, recovering energy and nutrients. Food and gut microbes are the main determinants of the human metabolome. Same foods can give rise to different circulating metabolites if the microbiome is different. Diet influences the composition and functions of the microbiome. Plant-based foods improve the diversity and functional quality of the microbiome. The tolerance of plant foods depends on the ability of the microbiome to process them. Plant food exclusion diets can worsen the functional capacity of the microbiome.
Azrieli Faculty of Medicine, Bar-Ilan University, Safed 1311502, Israel
Center for Nutrition Research, Department of Nutrition, Food Science and Physiology, University of Navarra, Pamplona, Spain
Laboratory of Molecular Biology, Nutrition and Biotechnology (Nutrigenomics, Biomarkers and Risk Evaluation Group), University of the Balearic Islands, Palma de Mallorca, Spain
Preventive Medicine and Public Health, Rovira i Virgili University, Reus, Spain
Department of Human Nutrition and Dietetics, Poznan University of Life Sciences, Poznan, Poland
Department of Nutrition, College of Agricultural and Environmental Sciences, University of California, Davis, CA 95616, USA
Faculty of Medical Sciences, Goce Delcev University, Krste Misirkov 10A, 2000, Stip, North Macedonia
University of Parma, Italy
Department of Nutritional Sciences, University of Connecticut, Storrs, CT, USA
Vydiant Inc., Dallas, TX, USA
Department of Nutritional Sciences, University of Arizona, Tucson, AZ, USA
List of accepted submissions (29)
Id | Title | Authors | Presentation Video | Poster PDF | |||||||||||||||||||||||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
sciforum-079426 | AG1, A Novel Foundational Nutrition Supplement, Demonstrates Increased Bioaccessibility and Bioavailability of Minerals Compared to a Tablet Multivitamin in vitro | , , , , , , , | N/A |
Show Abstract |
|||||||||||||||||||||||||||||||||||||
More than 57% of US adults take dietary supplements with the most common being daily multivitamins. Daily multivitamins are typically formulated in a pill or tablet form, however new options using a powder form to be mixed with diluent (water) are being utilized to increase bioavailability. While limited data is available, the theory is that multivitamins tablets must be adequately dissolved before entering the small intestine for assimilation, while powders come pre-dissolved before consumption and theoretically ensures enhanced bioavailability. Our aim was to investigate the bioaccessibility and bioavailability of minerals [magnesium (Mg), zinc (Zn), calcium (Ca), and potassium (K)] using a novel Foundational Nutrition supplement called AG1 compared to a tablet multivitamin. AG1 contains vitamins and minerals comparable to multivitamin tablets, but also includes prebiotics, probiotics, and phytonutrients. We employed the adapted Simulator of Human Intestinal Microbial Ecosystem (SHIME®) model to assess bioavailability and bioaccessibility of the study products using a simulated stomach and small intestine physiological environment equipped with a dialysis membrane (methylcellulose) to emulate absorption. Luminal contents were collected at the end of the stomach, duodenum, and 1-, 2-, and 3-hours after small intestine absorption simulation (dialysis) to assess bioaccessibility. The dialysis solution was measured at 1-, 2-, and 3-hours to assess bioavailability. A significantly higher (p < 0.05) percentage of the total amount of all minerals given at baseline was present at the end of the stomach and duodenum portion for the powder form vs. the tablet. There was a significantly higher % concentrationmaximum (Cmax) for Mg, Ca, and Zn for AG1 vs. tablet. Similarly, Mg, Ca, and Zn were more bioavailable but only Ca and Zn were more bioaccessible for AG1 compared to tablet. These preclinical data demonstrate that a greater proportion of minerals in AG1 enter the small intestine, have a higher Cmax, and several are more bioaccessible and bioavailable than a tablet multivitamin in vitro. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-079429 | Precision Neuronutrition: Personalized Approaches for Optimizing Brain Health | , , , , | N/A | N/A |
Show Abstract |
||||||||||||||||||||||||||||||||||||
Neuronutrition is defined as an interdisciplinary area that studies the influence of various aspects of nutrition on brain health prevention, and treatment of neurological disorders across the lifespan. The brain requires specific nutrients to maintain its structural integrity, support cognitive processes, and protect against neurodegenerative diseases. Leveraging advancements in genetic testing, metabolomics, and other cutting-edge technologies, precision neuronutrition aims to identify personalized nutrient requirements to optimize brain health outcomes and prevent neurological disorders. In this scoping review, we synthesized recent data on biomarkers indicative of brain health status, such as neuroinflammation, oxidative stress markers, gut-brain disturbances, and nutrient deficiencies. These biomarkers could provide real-time feedback on the effectiveness of dietary interventions. For instance, the evaluation of neuroinflammation hinges upon quantification of C-reactive protein, interleukin-6, and tumor necrosis factor-alpha. Oxidative stress is amenable to assessment through quantification of malondialdehyde and 8-hydroxy-2'-deoxyguanosine levels. Equilibrium pertaining to the gut-brain axis finds reflection in the proportions of short-chain fatty acids, composition of the microbiota consortium. Moreover, deficiencies in essential nutrients such as B vitamins, vitamin D, omega-3 fatty acids, and choline can serve as discernible indicators of brain health status. Additionally, we analyzed personalized interventions (diets and nutrient supplementation) for maintaining brain health and optimizing outcomes to provide a comprehensive overview of nutriomics. High consumption of fruits and vegetables can reduce mucosal inflammation, which is one of the reasons for neuroinflammation and impaired neurotransmitter metabolism.. Nutrients including tryptophan, vitamin B6, vitamin B12, folic acid, phenylalanine, tyrosine, histidine, magnesium, choline and glutamic acid were found to be effective in the regulation of mood, appetite and cognitive function. Precision neuronutrition offers a promising approach to optimize brain health through personalized dietary interventions. Continued research in this field hold great potential for revolutionizing the way we approach nutrition for the brain and improving brain health outcomes. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-079188 | Barriers to Accessing Medical Services and Adherence to Recommended Drug Regimens among Patients with Non-Communicable Diseases: A Study at Divisional Hospital Thalangama, Sri Lanka | , , , , , , , | N/A | N/A |
Show Abstract |
||||||||||||||||||||||||||||||||||||
Non-Communicable Diseases (NCDs) are the primary global cause of death, with profound negative effects on individuals, families, communities, and healthcare systems. The escalating burden of chronic illnesses, particularly in low and middle-income countries, necessitates effective disease management. This study investigates barriers to medical service access and adherence to prescribed regimens for NCD patients attending Divisional Hospital Thalangama's NCD clinics. Conducted through a descriptive cross-sectional approach, the study engaged 400 participants via random sampling. Data collection employed a pre-tested questionnaire with five sections, and analysis featured descriptive and inferential statistics, including Chi-Square tests using SPSS version 25 and Microsoft Excel. Ethical clearance and permissions were obtained from relevant authorities.Demographic findings reveal a sample primarily composed of married, Buddhist, Sinhalese females (56%), with a mean age of 63.0 ± 10 years and income of 34,462.65 ± 16,496.7 LKR. A majority had primary education (73.5%) and was unemployed (53%). Notably, most refrained from alcohol (75.5%) and smoking (81.25%).Prevalent NCDs were diabetes type-II (69.3%), hyperlipidemia (79.3%), and hypertension (84.3%), with average disease durations of 9.16 ± 6.29 years for hypertension and 9.7 ± 7.13 years for diabetes type-II. Key prescribed drug groups included Angiotensin II receptor antagonists (54.3%), Biguanides (64%), Sulfanauria (49.8%), and dyslipidemia drugs (82.3%).Adherence to recommended diets was low, with only 22.5% and 25% following diabetic and low sodium diets, respectively. Aerobic exercises and jogging were undertaken by 21.3% and 51%, while larger proportions abstained from aerobic exercises (31.3%), exercise (64.3%), sports (89%), yoga (96.8%), and Ayurveda (90.8%) for NCD management.The study's outcomes emphasize the urgency of overcoming barriers to medical service access and adherence for optimal NCD management. Tailored interventions can enhance patient outcomes, alleviate healthcare strain, and curtail NCD-related burdens on societies. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-079217 | "Exploring Diabetes Self-Management Behaviors among Patients at District General Hospital Polonnaruwa, Sri Lanka: A Comprehensive Analysis" | , , , , , , , , | N/A | N/A |
Show Abstract |
||||||||||||||||||||||||||||||||||||
This research delves into diabetes self-management practices among patients at District General Hospital Polonnaruwa's medical clinic. A comprehensive dataset from 100 participants over two weeks reveals insights. The majority were male (77%) from the Sinhala Buddhist community (97%). Education varied from up to O/L qualifications (53%) to no formal education (26%), while 63% were employed and 27% unemployed. Challenges in dietary adjustments, physical activity, and timely insulin administration were evident. Focus on dietary patterns highlighted the need to reduce rice consumption and increase protein and vegetable intake. Physical activity was evenly distributed, with 50% inactive and 50% active. Awareness of hyperglycemic management was notable, but gaps existed in foot care consciousness (41%) and recognizing familial diabetes history (28%). Complications like retinopathy (65%), neuropathy (33%), and nephropathy (22%) were significant concerns. Therapeutic drug familiarity was proficient, with 89% knowing oral hypoglycemic drugs and 21% understanding insulin. Education played a crucial role, shaping hygiene and self-management awareness. Complications were pertinent, but neuropathy and nephropathy instances were comparatively lower. Contributory factors—personal hygiene, physical activity, family support, dietary habits, and foot care—shaped diabetes self-management. Education emerged as a catalyst. Specific domains need attention for optimal outcomes. Dietary paradigms gain significance, emphasizing protein and vegetable integration. Surprisingly, 54% demonstrated commendable dietary practices, challenging previous claims of suboptimal approaches among Type 2 Diabetes Mellitus participants (56.7%). This study underscores education's pivotal role and the importance of addressing self-management domains for improved diabetes outcomes. |
|||||||||||||||||||||||||||||||||||||||||
sciforum-079313 | Polyunsaturated fatty acids intake in young individuals attending an English university. | , , , , | N/A | N/A |
Show Abstract |
||||||||||||||||||||||||||||||||||||
Omega-3 long-chain polyunsaturated fatty acids (PUFAs) such as eicosapentaenoic acid (EPA), docosahexaenoic acid (DHA), are poorly synthesised in the human body, and are substantially lower in Western diets compared with their shorter chain omega-3 essential fatty acid precursors α-linolenic acid (18:3n-3; ALA). However, ALA does not provide the health benefits observed with the intake of EPA and DHA, which have been associated with healthy aging, and importance in foetal development and neural, retinal and immune system function. The aim of our work was to assess intake of PUFAs, EPA, DHA and ALA in a young cohort of students attending De Montfort University (DMU), a British university located in the East Midlands. Comprehensive nutrient intake was collected from 111 (20.45 ± 1.16 yrs-old; 78 female) DMU students between 2015-16 from three major ethnic backgrounds (41 Asia, 41 Africa, 27 Europe), using a validated variant of the Nutrition Norfolk Food Frequency Questionnaire with more than 130 food items, which also records portion size. Questionnaires were processed with Nutritics dietary software. BMI values were calculated with the formula BMI = kg/m2. Moreover, body total and visceral fat, water, muscle and bone mass were directly obtained by a Tanita scale. Only 9.2% of this population was underweight, meanwhile 25.7% and 8.3% were overweight and obese, respectively; three times the national average in this age group. The dietary intakes of total fat (100.55 vs. 81.72 all in g/day; p-value=0.032), total polyunsaturated fatty acids (PUFA; 14.61 vs. 12.91; NS), linoleic acid (18:2n-6; LA; 27.254 vs. 19.506; p-value=0.0019), ALA (5.857 vs. 3.725; p-value=0.00008), arachidonic acid (AA; 0.765 vs. 0.578; p-value=0.0303), EPA (0.620 vs. 0.523; NS) and DHA (1.069 vs. 0.847; NS) were significantly higher or higher in male participants, respectively. The high intakes of LA and ALA versus EPA and DHA observed would be consistent with that reported in Western countries. However, none of them presented statistical differences according to ethnic background or BMI, except for the intake of total fat (p-value=0.0069) and PUFA (p-value=0.0013), which were significantly higher in students from Asia and Europe. However, although without significance, the higher intakes of EPA and DHA were seen in Asian [values as mean and range (in g/day); 1.006 (0.011-5.724) and 0.605 (0.032-3.484)] and African [0.875 (0.075-5.064) and 0.545 (0.067-3.586)] students versus European [0.826 (0.089-2.810) and 0.480 (0.0498-1.755)], possibly due to differences in the diet between these individuals based on their different traditions. The dietary intakes of DHA plus EPA in the group monitored (0.551 + 0.912 g/day) exceed the recommended intake of 0.2 g/day recommended by the UK, including the RDI of 0.5 g/day that considers the intake of one to two portions of fish per week. The higher intakes of EPA and DHA in the monitored group than that reported in 19-24 years-old UK population (97 and 98 mg/day, in males and females, respectively) could be explained by the higher intake of fish observed (59.4) when compared with that reported in general UK adult population (31 g/day). However, the intake of total fish was higher in Asian and European students than those reported in African participants (65.895, 63.899 vs. 49.972 g/day), although these differences were not statistically different. Further analysis will evaluate the potential contribution of poultry, milk and eggs to the intake of EPA and DHA in the monitored group for each ethnical background. Finally, male and female participants (1.817 and 1.503) would cover the adequate intake of omega-3s (1.6 and 1.1; g/day) established by the US National Institutes of Health. |
Instructions for Authors
Submissions should be made by the authors online by registering with iecn2023.sciforum.net, and using the "Submit Abstract/New Submission" function once logged into the system.
Note: Institutional email address is requested especially for the corresponding author. Please submit the abstract with the institutional email address.
- Scholars interested in participating in this conference can submit their communication abstracts (about 200–300 words) online on this website until 14th July 2023 10th August 2023.
- Abstracts will be evaluated based on their scientific quality and suitability for the conference sections. All authors will be notified by 30th July 2023 21st August 2023 regarding the acceptance of their abstract for the 3rd International Electronic Conference on Nutrients.
- Once the abstract has been accepted, the author is requested to submit their manuscript (short proceedings paper, 3–6 pages) before 15th September 2023. Optionally, authors of accepted abstracts will be able to submit a poster, a slides presentation (in PDF) and/or a short video presentation (max. 3–5 minutes) as supporting material for the paper. You can submit the full paper by accessing My Submission.
The text in the abstract must match that presented in the full communication. Those abstracts that are not completed with full communication will be withdrawn by the editors. PowerPoint presentations or videos are complements to the full communication and cannot be presented as a substitute for it.
Note: Before publication, the manuscripts and/or supplementary files will be checked by using the powerful text comparison tool: iThenticate. This procedure aims to prevent scholarly and professional plagiarism. Submissions will then be peer-reviewed by conference committees based on originality/novelty, quality of presentation, scientific soundness, interest to the readers, overall merit and English level. Please kindly ensure that the proceeding paper you submit is original and unpublished. Articles with a high repetition rate and lack of novelty will NOT be accepted in the conference proceedings. - The conference proceedings papers and presentations will be available on https://iecn2023.sciforum.net/ for discussion and rating during the time of the conference, from 1st-15th November 2023.
- The accepted proceedings papers(3–6 pages) will probably be published as one dedicated volume in MDPI Biology and Life Sciences Forum (ISSN 2673-9976).
Note: Publication of proceedings paper is free of charge. Before publication, Biology and Life Sciences Forum journal will check the plagiarism issue again. Submissions with a lack of novelty will not be published in the journal. - Participants of this conference are cordially invited to contribute a full manuscript to a dedicated Special Issue in the journal Nutrients (ISSN 2072-6643, IF 5.9 (2022)). Papers presented at the conference will be granted a 20% discount in the Special Issue.
Note: The submission to the journal is independent of the conference proceedings and will follow the usual process of the journal, including peer review, APC, etc.
- Title
- Full author names
- Affiliations (including full postal address) and authors' e-mail addresses
- Abstract
- Keywords
- Introduction
- Methods
- Results and Discussion
- Conclusions
- (Acknowledgments)
- References
Authors are encouraged to prepare a presentation in PowerPoint, or similar software, to be displayed online along with the manuscript. Slides, if available, will be displayed directly on the website using the https://sciforum.net/event/IECN2023 proprietary slide viewer. Slides can be prepared in the same way as for any traditional conference where research results are presented. Slides should be converted to PDF format before submission so that our process can easily and automatically convert them for online display.
Posters will be available on this conference website during and after the event. As with papers presented on the conference, participants will be able to ask questions and make comments about the posters. Posters can be presented without an accompanying proceedings paper.
After acceptance, please upload a copy of the proceedings/abstract as a PDF and Word document, in the corresponding fields, and upload the Poster PDF in the field "Presentation PDF (optional)".
1)The poster should be in PDF format
2)The minimum size for images is 148 mm × 210 mm (horizontal × vertical) at 300 dpi.
3)The content of the poster should be a comprehensive presentation of your accepted submission.
4) There should be no copyright issues with any elements in the poster.
For detailed instructions on how to submit a poster, please contact us.
- MS Word: Manuscripts prepared in MS Word must be converted into a single file before submission. When preparing manuscripts in MS Word, the Electronic Conference on Agronomy Microsoft Word template file (see download below) must be used. Please do not insert any graphics (schemes, figures, etc.) into a movable frame, as this can superimpose the text and make the layout very difficult.
- LaTeX: Manuscripts prepared in LaTeX must be collated into one ZIP folder (include all source files and images so that the Conference Secretariat can recompile the submitted PDF). When preparing manuscripts in LaTeX, please use the provided LaTeX template file.
The IECN 2023 Microsoft Word template file and LaTeX template file:
Paper Format: Papers should be in A4 paper format, with a printing area of 17.5 cm × 26.2 cm. The margins should be 1.75 cm on each side of the paper (top, bottom, left, and right sides).
- Formatting/Style: Papers should be prepared following the style of Nutrients. The full titles and the cited papers must be given. Reference numbers should be placed in square brackets and placed before the punctuation; for example, [1,2], [3] or [1–3]. All the references should be listed separately in full detail as the last section at the end of the manuscript.
- Author List and Affiliation Format: Authors' full first and last names must be given. Abbreviated middle names can be added. For papers written by various contributors, a corresponding author must be designated. The PubMed/MEDLINE format is used for affiliations: complete street address information, including city, zip code, state/province and country, and email address should be added. All authors who contributed significantly to the manuscript (including writing a section) should be listed on the first page of the manuscript, below the title of the article. Other parties who provided only minor contributions should be listed under Acknowledgments only. A minor contribution might be a discussion with the author, reading through the draft of the manuscript, or performing English corrections.
- Figures, Schemes and Tables: Authors are encouraged to prepare figures and schemes in color. Full-color graphics will be published free of charge. Figures and schemes must be numbered (Figure 1, Scheme I, Figure 2, Scheme II, etc.) and an explanatory title must be added. Tables should be numbered, titled and inserted into the main text. All table columns should have an explanatory heading. Please supply legends for all figures, schemes and tables. The legends should be prepared as a separate paragraph of the main text and placed in the main text before a table, a figure or a scheme.
It is the authors' responsibility to identify and declare any personal circumstances or interests that may be perceived as inappropriately influencing the representation or interpretation of clinical research. If there is no conflict, please state here "The authors declare no conflict of interest." This should be conveyed in a separate "Conflict of Interest" statement preceding the "Acknowledgments" and "References" sections at the end of the manuscript. Financial support for the study must be fully disclosed under the "Acknowledgments" section.
MDPI, the publisher of the Sciforum.net platform, is an open access publisher. We believe that authors should retain the copyright to their scholarly works. Hence, by submitting a paper to this conference, you retain the copyright of your paper, but you grant MDPI the non-exclusive right to publish this paper online on the Sciforum.net platform. This means you can easily submit your paper to any scientific journal at a later stage and transfer the copyright to its publisher (if required by that publisher).
Besides their active participation in the forum, authors are also encouraged to submit video presentations. If you are interested in submitting a video presentation, authors are also encouraged to submit video presentations. This is a unique way of presenting your paper and discussing it with peers worldwide. The video should be no longer than 3-5 minutes and prepared with one of the following formats: .mp4 / .webm / .ogg (max size: 250Mb). It should be submitted with the full manuscript before 15th September 2023. This is a unique way of presenting your paper and discussing it with peers worldwide. Make a difference and join us for this project!
Tips: Video should be no longer than 3-5 minutes and prepared with one of the following formats: .mp4 / .webm / .ogg (max size: 250Mb).
Event Awards
To acknowledge the support of the conference's esteemed authors and recognize their outstanding scientific accomplishments, we are pleased to launch the Best Proceedings Paper Award and Best Poster/Video Presentation Award.
Winner Announcement:
On behalf of the chairs of IECN2023, we are pleased to announce the winners of the Best Proceedings Paper Award and Best Poster/Video Presentation Award.
The Best Proceedings Paper Award have been awarded to
- sciforum-074529, "25-Hydroxyvitamin D Serum Levels Linked to Single Nucleotide Polymorphisms (SNPs) (rs2228570, rs2282679, rs10741657) in Sports Performance in Elite Athletes", Diego Fernández Lázaro, Ana M. Celorrio San Miguel, Jesús Seco Calvo, Enrique Roche, Cesar Ignacio Fernández Lázaro.
The Best Poster Award have been awarded to
- sciforum-073559, "Impact of FADS and ELOVL2/5 Genetic Variation on Fatty Acid and Cardiometabolic Endpoints in Mexican American Individuals", Sarah Ashley Blomquist, Jil Hope Albrecht, Brian Hallmark, Yann Klimentidis, Luis A. Garcia, Lawrence J Mandarino, Dawn K Coletta, Floyd H Chilton.
The Awards
Number of Awards Available: 1
The Best Proceedings Paper Award is given for the paper judged to make the most significant contribution (proceedings paper) to the conference. The award will be CHF 500 (Swiss Francs). We look forward to posting your contributions.
Criteria
● Full paper must be submitted to Nutrients in 2023.
● Originality/novelty of the paper.
● Significance of content.
● Scientific soundness.
● Interest to the readers.
● English language and style.
Evaluation
Each Evaluation Committee member will give an assessment for each applicant in terms of the criteria outlined above.
Total score for each presentation will be ranked, from highest to lowest.
If two or more authors get the same score, further evaluation will be carried out.
All decisions made by the Evaluation Committee are final.
Number of Awards Available: 1
The Best Poster Award has been established to recognize the scientific merit exhibited in poster and video presentations and preparation. The award will be CHF 500 (Swiss Francs). We look forward to posting your contributions.
Criteria
● Title (with authors and affiliations).
● Introduction / Objectives / Aims.
● Methods.
● Results.
● Conclusion.
● References.
● Acknowledgements.
● Contact information.
● Video presentation.
Evaluation
During the conference, the chair is invited to judge the quality of the 3-minute video presentation and poster. The criteria of judgement on the presentation shall be the ability to summarize the content of the work and the interest that the poster gains. The criteria of judgement on the poster should be the clarity of the poster and the quality of its appearance.
Conference Secretariat
A. Epigenetics in Nutrigenomics and Precision Nutrition
Session Chair
Prof. Dr. M. Luisa Bonet, SEIC of Nutrients Nutrigenomic and Obesity Research Group, Laboratory of Molecular Biology, Nutrition and Biotechnology (LBNB), University of the Balearic Islands, Palma de Mallorca, Spain
Show all published submissions (2) Hide published submissions (2)
Submissions
List of Papers (2) Toggle list
B. Genetic Polymorphisms, Precision Nutrition and Exercise Performance
Session Chair
Prof. Dr. Maria Luz Fernandez, EIC of Nutrients
Show all published submissions (5) Hide published submissions (5)
Submissions
List of Papers (5) Toggle list
C. The Role of Gut Microbiota in Precision Nutrition
Session Chair
Dr. Francisco J. Pérez-Cano, SEIC of Nutrients Section of Physiology, Department of Biochemistry and Physiology, Faculty of Pharmacy and Food Sciences, University of Barcelona, 08028 Barcelona, Spain, Nutrition and Food Safety Research Institute (INSA), 08921 Santa Coloma de Gramenet
Show all published submissions (10) Hide published submissions (10)
Submissions
List of Papers (10) Toggle list
D. Nutriomics Approaches in Precision Nutrition
Session Chair
Dr. Egeria Scoditti, National Research Council –Institute of Clinical Physiology, Lecce Section, Laboratory of Vascular Biology and Nutrigenomics, Ecotekne Campus, Via Monteroni, 73100 Lecce, Italy
Show all published submissions (12) Hide published submissions (12)
Submissions
List of Papers (12) Toggle list